← Leaderboards
Kyoji Tsuchikama
University Of Texas Hlth Sci Ctr Houston
$3,574,789
Attributed
$3,901,164
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,901,164 · 3
By mechanism
R01$1,951,164 · 2
R35$1,950,000 · 1
Top collaborators
- Jann N Sarkaria1 shared
Most similar at University Of Texas Hlth Sci Ctr Houston
Same institution · by research overlap
- Qing Yang$2,535,206
- Qingyun Liu$2,770,299
- Kendra S. Carmon$3,557,490
- Tae Jin Lee$156,000
Others in their field
Other Emerging Leaders on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Lynn Briscoe · Leidos Biomedical Research, Inc.$97,151,761
- Beth Baseler · Leidos Biomedical Research, Inc.$87,027,148
Research focus
Pharmaceutical PreparationsPeptidesDrug KineticsDesignTechnologySafetyAntibodiesTumorEffective TherapyAntibody-Drug ConjugatesModalityNovel TherapeuticsTreatment EfficacyCellsMouse ModelIn VivoFoundationsKineticsBiodistributionSitePlasmaBrain NeoplasmsBrainMonoclonal Antibodies
Grant awards (9)
Antibody Drug Conjugate Designs to Enhance the Therapeutic Window for Brain Tumors$652,751
R01 · FY2025 · NS
Antibody-dual drug conjugates for eradicating triple-negative breast cancer with heterogeneity$419,275
R01 · FY2025 · CA · contact PI
Antibody-dual drug conjugates for eradicating triple-negative breast cancer with heterogeneity$397,082
R01 · FY2024 · CA · contact PI
Chemical approaches for generating blood-brain barrier-permeable antibody conjugates$390,000
R35 · FY2024 · GM · contact PI
Antibody-dual drug conjugates for eradicating triple-negative breast cancer with heterogeneity$482,056
R01 · FY2023 · CA · contact PI
Chemical approaches for generating blood-brain barrier-permeable antibody conjugates$390,000
R35 · FY2023 · GM · contact PI
Chemical approaches for generating blood-brain barrier-permeable antibody conjugates$390,000
R35 · FY2022 · GM · contact PI
Chemical approaches for generating blood-brain barrier-permeable antibody conjugates$390,000
R35 · FY2021 · GM · contact PI
Chemical approaches for generating blood-brain barrier-permeable antibody conjugates$390,000
R35 · FY2020 · GM · contact PI